Kidney cancers originate from kidney tissue and occupy an important place in urological oncology. The disease often shows no symptoms at an early stage and may be discovered incidentally during imaging performed for other reasons.
At advanced stages, symptoms such as flank pain, blood in the urine, a palpable mass, fatigue and weight loss can occur. For this reason, early diagnosis in kidney cancers is of critical importance for treatment success.
Imaging plays the primary role in diagnosing kidney cancers. Ultrasonography, computed tomography and magnetic resonance imaging assess the size, location and relationship to surrounding tissue of the kidney mass in detail.
Additional tests may be performed when necessary to determine the extent of the disease. This evaluation determines the tumor's type and stage, forming the basis of treatment planning.
Treatment of kidney cancers is planned according to the tumor's stage, size, location and the patient's general health. Surgery is the primary treatment option in most cases, and minimally invasive surgical approaches may also be considered in suitable patients.
The main goal of the treatment process is to effectively remove the cancerous tissue, preserve kidney function as much as possible and control the disease.
After surgery or other treatment approaches, patients are placed on a regular follow-up program. The course of the disease is monitored with imaging and clinical assessments.
This follow-up process is very important for detecting recurrences early and achieving healthy long-term results.
